America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on October 21, 2026

SCYNEXIS to Feature SCY-247 in a Pipeline Presentation at IDWeek
BioCryst to Report Third Quarter 2026 Financial Results on November 4
Weir and Quatro Metales feature in new Investors Guide to Mining issue focused on tailings intelligence
Marketing + HR + Sales = One Distribution Engine: PeopleSocial's 2026 State of Employee-Led Distribution
Discovery Announces Details of Third Quarter 2026 Results Conference Call and Webcast
El futuro de los viajes comienza ahora: arranca el Día Global de Experiencia Tecnológica JETOUR 2026
Metsa Tanks Announces Executive Leadership Changes
NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward
Consolidated Water Advances Permitting for Kalaeloa Seawater Desalination Project in Hawaii
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
Critical Metals Corp. Announces Share Scheme Transaction Ratio for Acquisition of European Lithium
Belo Sun Receives Decision on Temporary Suspension of License Until Result of Settlement Hearing
Bastion Trading Calls on SkyAI Chairman and Directors to Demonstrate Accountability and to Provide a Better Tender Offer for All Stockholders and Pre-Funded Warrant Holders
Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
Elion Therapeutics to Present Turletricin Clinical Data at IDWeek 2026
Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer
Sundance Biosciences Announces Presentation of Phase 1 Results for SUN-627, a Brain-Penetrant TYK2 Inhibitor for the Treatment of Multiple Sclerosis (MS)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

America Latina Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.